Regeneron Pharmaceuticals Surges to 79th in Trading Volume with $1.09 Billion in Shares Traded

On June 9, 2025, Regeneron Pharmaceuticals, Inc. (REGN) saw a significant increase in trading volume, with a total of $1.09 billion in shares traded, marking a 36.24% rise from the previous day. This surge placed Regeneron at the 79th position in terms of trading volume for the day. The stock has been on an upward trajectory, rising 4.94% on the day and 7.15% over the past two days.

Regeneron Pharmaceuticals, Inc. participated in the Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025. This event provided a platform for the company to present its latest developments and strategic initiatives to investors and industry experts.

In a recent announcement, Regeneron Pharmaceuticals, Inc. and Sanofi presented results from a collaborative study. The findings highlighted the potential of their joint efforts in advancing medical research and development, which could have a positive impact on the company's future prospects.